{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/ja/reddit/r/stocks/comments/o8fqex/ntla_and_regn_announce_that_they_have/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"RedditPost-ba12f047-e2f4-5925-8edf-111fd9e33c0c","excerpt":"Big news in the medical field today as Intellia Therapeutics and Regeneron\nannounce, for the first time, history-making news that they have successfully\ntreated a genetic disease, ATTR amyloidosis, with a single infusion of CRISPR, a\nprogrammable gene editing tool. This data was also published in…","body":"<!-- SC_OFF --><div class=\"md\"><p>Big news in the medical field today as Intellia Therapeutics and Regeneron announce, for the first time, history-making news that they have successfully treated a genetic disease, ATTR amyloidosis, with a single infusion of CRISPR, a programmable gene editing tool. This data was also published in the premiere medical journal, NEJM</p>\n\n<p><a href=\"https://ir.intelliatx.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing\">https://ir.intelliatx.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing</a></p>\n\n<p><a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa2107454?query=featured_home\">https://www.nejm.org/doi/full/10.1056/NEJMoa2107454?query=featured_home</a></p>\n\n<p>For those unaware, CRISPR is a programmable gene editing system discovered in 2012 which allows precise gene editing at a target locus. Jennifer Doudna, the founder of NTLA, and Emannuelle Charpentier, the founder of CRSP, were awarded the 2020 Nobel Prize in Chemistry.</p>\n\n<p>This really demonstrates the promise of CRISPR to treat all genetic diseases. </p>\n\n<p>I believe this will cause the entire sector of gene editing and maybe genomics stocks to move higher. Other stocks in this field include BEAM, EDIT, VERV, VRTX, and CRSP.</p>\n\n<p>Some additional articles:</p>\n\n<p><a href=\"https://www.npr.org/sections/health-shots/2021/06/26/1009817539/he-inherited-a-devastating-disease-a-crispr-gene-editing-breakthrough-stopped-it?fbclid=IwAR0pufLeRHs8QGStWirHjLpAyw0WF8wVnOZ-oRuHPu520tGZ4J2Scmwpxd4\">https://www.npr.org/sections/health-shots/2021/06/26/1009817539/he-inherited-a-devastating-disease-a-crispr-gene-editing-breakthrough-stopped-it?fbclid=IwAR0pufLeRHs8QGStWirHjLpAyw0WF8wVnOZ-oRuHPu520tGZ4J2Scmwpxd4</a></p>\n\n<p><a href=\"https://www.sciencemag.org/news/2021/06/crispr-injected-blood-treats-genetic-disease-first-time\">https://www.sciencemag.org/news/2021/06/crispr-injected-blood-treats-genetic-disease-first-time</a></p>\n\n<p><a href=\"https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/\">https://www.statnews.com/2021/06/26/intellia-therapeutics-ntla-2001-data/</a></p>\n</div><!-- SC_ON -->","slug":"/reddit/r/stocks/comments/o8fqex/ntla_and_regn_announce_that_they_have/","title":"$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR","tags":["stocks","reddit"],"date":"June 26, 2021","dateISO":"2021-06-26T20:50:31.000Z","datetime":"2021-06-26 20:50","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"ba12f047-e2f4-5925-8edf-111fd9e33c0c","provider":"Reddit","url":"https://www.reddit.com/r/stocks/comments/o8fqex/ntla_and_regn_announce_that_they_have/","originalUrl":"https://www.reddit.com/r/stocks/comments/o8fqex/ntla_and_regn_announce_that_they_have/","imageRemote":null,"video":null,"channel":"stocks","channelUrl":"https://www.reddit.com/r/stocks","author":"Social_History","authorUrl":"https://www.reddit.com/user/Social_History","authorImage":null,"authorImageRemote":null,"authorSlug":"Social_History","score":1098,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"$NTLAと$REGNがCRISPRの注入で遺伝性疾患の改善に成功したと発表","the_new_excerpt":"Intellia Therapeutics社とRegeneron社が本日、医療分野でのビッグニュースを発表しました。\nが、遺伝子疾患であるATTRアミロイドーシスの治療に成功したという歴史的なニュースが発表されました。\n遺伝病であるATTRアミロイドーシスを、プログラム可能な遺伝子編集ツールであるCRISPRを1回の注入で治療することに成功したと発表しました。\n遺伝病であるATTRアミロイドーシスの治療に成功したことを発表しました。また、このデータは...","locale":"ja"},{"title":"$NTLA和$REGN宣布，他们已经成功地用CRISPR输液纠正了一种遗传性疾病","the_new_excerpt":"今天医学领域的重大新闻是Intellia Therapeutics公司和Regeneron公司\n首次宣布了一个创造历史的消息：他们已经成功地\n用CRISPR的单次注射治疗一种遗传性疾病--ATTR淀粉样变性。\n可编程的基因编辑工具。这一数据也被发表在...","locale":"zh"},{"title":"$NTLA和$REGN宣佈，他們已經成功地用CRISPR輸液糾正了一種遺傳性疾病","the_new_excerpt":"今天醫學領域的重大新聞是Intellia Therapeutics公司和Regeneron公司\n首次宣佈了一個創造歷史的消息：他們已經成功地\n用CRISPR的單次注射治療一種遺傳性疾病--ATTR澱粉樣變性。\n可編程的基因編輯工具。這一數據也被髮表在...","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-695a4cb1-8b31-5302-b05e-3a433d541561","excerpt":"I've read a lot about boring stocks:\n\nhttps://finance.yahoo.com/news/10-boring-stocks-important-portfolio-120022679.html\n\nhttps://investorplace.com/2020/08/9-boring-stocks-to-buy-you-should-never-let-go-of/\n\nhttps://www.kiplinger.com/slideshow/investing/t052-s001-11-boring-but-beautiful-dividend…","slug":"/reddit/r/investing/comments/o808c7/is_it_normal_to_not_get_excited_about_the_stocks/","title":"Is it normal to not get excited about the stocks in your portfolio? [crisis]","date":"June 26, 2021","__typename":"SocialMediaPost","parent":{"localize":[{"title":"自分のポートフォリオの銘柄にワクワクしないのは当たり前？危機感】を","the_new_excerpt":"つまらない株についてはよく読んでいます。\n\nhttps://finance.yahoo.com/news/10-boring-stocks-important-portfolio-120022679.html\n\nhttps://investorplace.com/2020/08/9-boring-stocks-to-buy-you-should-never-let-go-of/\n\nhttps://www.kiplinger.com/slideshow/investing/t052-s001-11-boring-but-beautiful-dividend...","locale":"ja"},{"title":"对你的投资组合中的股票不感到兴奋是正常的吗？[危机]","the_new_excerpt":"我读了很多关于无聊股票的文章。\n\nhttps://finance.yahoo.com/news/10-boring-stocks-important-portfolio-120022679.html\n\nhttps://investorplace.com/2020/08/9-boring-stocks-to-buy-you-should-never-let-go-of/\n\nhttps://www.kiplinger.com/slideshow/investing/t052-s001-11-boring-but-beautiful-dividend...","locale":"zh"},{"title":"對你的投資組合中的股票不感到興奮是正常的嗎？[危機]","the_new_excerpt":"我讀了很多關於無聊股票的文章。\n\nhttps://finance.yahoo.com/news/10-boring-stocks-important-portfolio-120022679.html\n\nhttps://investorplace.com/2020/08/9-boring-stocks-to-buy-you-should-never-let-go-of/\n\nhttps://www.kiplinger.com/slideshow/investing/t052-s001-11-boring-but-beautiful-dividend...","locale":"zh-Hant"}]}},"next":{"id":"RedditPost-02749a6e-4e1d-59ef-94e8-d15d9335a5fc","excerpt":"Curious about everyone’s age, portfolio strategy, total and allocation given\nthis raging bull market. Most of the threads I found were 4-7 years old.\n\n * 33yo\n * 370k retirement (100% VOO)\n * 240k post tax (92% VOO, 8% AMZN, 2.5% VGT)\n * no house (renter), debt or cash holdings (aside from emergency…","slug":"/reddit/r/stocks/comments/o8dxux/whats_your_current_portfolio_strategy_total_and/","title":"what’s your current portfolio strategy, total and allocation?","__typename":"SocialMediaPost","date":"June 26, 2021","parent":{"localize":[{"title":"現在のポートフォリオの戦略、総量、配分はどうなっていますか？","the_new_excerpt":"皆さんの年齢、ポートフォリオ戦略、合計、この猛烈な強気相場での配分について興味があります。\nこの猛烈な強気の市場の中で、皆さんの年齢、ポートフォリオ戦略、合計、配分について興味があります。私が見つけたスレッドのほとんどは4～7年前のものでした。\n\n * 33歳\n * 370k 退職金 (100% VOO)\n * 240k post tax (92% VOO, 8% AMZN, 2.5% VGT)\n * 家（借家）、借金、現金を持たない（緊急時を除いて...","locale":"ja"},{"title":"你目前的投资组合策略、总额和配置是什么？","the_new_excerpt":"很好奇大家的年龄、投资组合策略、总额和分配情况，因为\n汹涌的牛市。我发现的大多数主题都是4-7年的。\n\n * 33岁\n * 37万退休金（100% VOO）。\n * 税后24万（92% VOO, 8% AMZN, 2.5% VGT)\n * 没有房子（租房者），没有债务或现金持有（除了应急...","locale":"zh"},{"title":"你目前的投資組合策略、總額和配置是什麼？","the_new_excerpt":"很好奇大家的年齡、投資組合策略、總額和分配情況，因爲\n洶湧的牛市。我發現的大多數主題都是4-7年的。\n\n * 33歲\n * 37萬退休金（100% VOO）。\n * 稅後24萬（92% VOO, 8% AMZN, 2.5% VGT)\n * 沒有房子（租房者），沒有債務或現金持有（除了應急...","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"RedditPost-ba12f047-e2f4-5925-8edf-111fd9e33c0c","previousId":"RedditPost-695a4cb1-8b31-5302-b05e-3a433d541561","nextId":"RedditPost-02749a6e-4e1d-59ef-94e8-d15d9335a5fc","maxWidth":1024,"siteMetadata":null,"locale":"ja","hrefLang":"ja-JA","originalPath":"/reddit/r/stocks/comments/o8fqex/ntla_and_regn_announce_that_they_have/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}